

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neurofilament cytoskeleton organization (GO:0060052) | 6.86409348 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.18684965 |
| 3 | regulation of RIG-I signaling pathway (GO:0039535) | 5.82991887 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.66748028 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.60268282 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 5.60268282 |
| 7 | neurotransmitter secretion (GO:0007269) | 5.46256055 |
| 8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.29827937 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.23864496 |
| 10 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.89133995 |
| 11 | respiratory electron transport chain (GO:0022904) | 4.84702693 |
| 12 | mast cell activation (GO:0045576) | 4.82051662 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 4.81201702 |
| 14 | electron transport chain (GO:0022900) | 4.68900580 |
| 15 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 4.67006536 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.66448959 |
| 17 | positive regulation of hormone biosynthetic process (GO:0046886) | 4.53650119 |
| 18 | negative regulation of T cell mediated immunity (GO:0002710) | 4.52308425 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.49214795 |
| 20 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.45627328 |
| 21 | cellular potassium ion homeostasis (GO:0030007) | 4.44380769 |
| 22 | righting reflex (GO:0060013) | 4.36387836 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.35160586 |
| 24 | protein localization to synapse (GO:0035418) | 4.31360848 |
| 25 | neuromuscular synaptic transmission (GO:0007274) | 4.30833907 |
| 26 | mature B cell differentiation involved in immune response (GO:0002313) | 4.29170466 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 4.24394899 |
| 28 | glutamate secretion (GO:0014047) | 4.23053683 |
| 29 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.17574858 |
| 30 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.17377416 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.16573802 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.14703101 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07133807 |
| 34 | layer formation in cerebral cortex (GO:0021819) | 4.04411982 |
| 35 | neuromuscular process controlling posture (GO:0050884) | 4.03263444 |
| 36 | cellular response to interleukin-15 (GO:0071350) | 3.99304618 |
| 37 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.96186696 |
| 38 | cell communication by electrical coupling (GO:0010644) | 3.95293554 |
| 39 | mast cell activation involved in immune response (GO:0002279) | 3.92401338 |
| 40 | mast cell degranulation (GO:0043303) | 3.92401338 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 3.91311900 |
| 42 | regulation of hypersensitivity (GO:0002883) | 3.89848579 |
| 43 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.88263206 |
| 44 | regulation of neurotransmitter levels (GO:0001505) | 3.87438765 |
| 45 | neurotransmitter transport (GO:0006836) | 3.83931319 |
| 46 | positive regulation of glycolytic process (GO:0045821) | 3.83836153 |
| 47 | neutrophil activation (GO:0042119) | 3.76070983 |
| 48 | response to interleukin-15 (GO:0070672) | 3.75873068 |
| 49 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.73708058 |
| 50 | regulation of vesicle fusion (GO:0031338) | 3.72558109 |
| 51 | B cell mediated immunity (GO:0019724) | 3.71173434 |
| 52 | intermediate filament organization (GO:0045109) | 3.69987900 |
| 53 | response to peptidoglycan (GO:0032494) | 3.67869943 |
| 54 | vitamin catabolic process (GO:0009111) | 3.63913293 |
| 55 | fat-soluble vitamin catabolic process (GO:0042363) | 3.63913293 |
| 56 | ATP biosynthetic process (GO:0006754) | 3.62668308 |
| 57 | axon cargo transport (GO:0008088) | 3.62205264 |
| 58 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.62134445 |
| 59 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.60394876 |
| 60 | positive regulation of mast cell degranulation (GO:0043306) | 3.60394876 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 3.60102561 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.57581403 |
| 63 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.56080777 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.53571599 |
| 65 | positive regulation of synapse maturation (GO:0090129) | 3.53163220 |
| 66 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.51415491 |
| 67 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.51415491 |
| 68 | mature B cell differentiation (GO:0002335) | 3.50121726 |
| 69 | adult walking behavior (GO:0007628) | 3.49956707 |
| 70 | positive regulation of protein sumoylation (GO:0033235) | 3.43361647 |
| 71 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.41459065 |
| 72 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.39755163 |
| 73 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.37499009 |
| 74 | granulocyte activation (GO:0036230) | 3.35991236 |
| 75 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.35431169 |
| 76 | regulation of synaptic vesicle transport (GO:1902803) | 3.35271037 |
| 77 | leukocyte degranulation (GO:0043299) | 3.34772502 |
| 78 | positive regulation of response to biotic stimulus (GO:0002833) | 3.34068941 |
| 79 | positive regulation of hormone metabolic process (GO:0032352) | 3.33112568 |
| 80 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.32527617 |
| 81 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.31591579 |
| 82 | nerve growth factor signaling pathway (GO:0038180) | 3.31487519 |
| 83 | neurotransmitter biosynthetic process (GO:0042136) | 3.31247650 |
| 84 | myeloid cell activation involved in immune response (GO:0002275) | 3.30776443 |
| 85 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.30109451 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.29613862 |
| 87 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.29237991 |
| 88 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.28944392 |
| 89 | potassium ion homeostasis (GO:0055075) | 3.27918473 |
| 90 | adenine nucleotide transport (GO:0051503) | 3.25575197 |
| 91 | mRNA transcription (GO:0009299) | 3.24413569 |
| 92 | tricarboxylic acid cycle (GO:0006099) | 3.23416363 |
| 93 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.21807739 |
| 94 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.21419305 |
| 95 | activation of protein kinase A activity (GO:0034199) | 3.21297536 |
| 96 | regulation of cell communication by electrical coupling (GO:0010649) | 3.20692615 |
| 97 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.20474884 |
| 98 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.20051647 |
| 99 | negative regulation of cell killing (GO:0031342) | 3.20051647 |
| 100 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.19979636 |
| 101 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.17481890 |
| 102 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.17376799 |
| 103 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.17225581 |
| 104 | positive regulation of B cell mediated immunity (GO:0002714) | 3.17130531 |
| 105 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.17130531 |
| 106 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.17035642 |
| 107 | lymphocyte chemotaxis (GO:0048247) | 3.16669143 |
| 108 | hydrogen ion transmembrane transport (GO:1902600) | 3.15893793 |
| 109 | purine nucleotide transport (GO:0015865) | 3.15889260 |
| 110 | regulation of mast cell activation (GO:0033003) | 3.15457383 |
| 111 | locomotory exploration behavior (GO:0035641) | 3.14806173 |
| 112 | tolerance induction (GO:0002507) | 3.14635868 |
| 113 | positive regulation of granulocyte differentiation (GO:0030854) | 3.14225860 |
| 114 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.14114865 |
| 115 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.14114865 |
| 116 | respiratory system process (GO:0003016) | 3.13516779 |
| 117 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.12659558 |
| 118 | negative regulation of cation channel activity (GO:2001258) | 3.10866079 |
| 119 | negative regulation of interleukin-12 production (GO:0032695) | 3.10358927 |
| 120 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.09960731 |
| 121 | activated T cell proliferation (GO:0050798) | 3.09303941 |
| 122 | leukocyte aggregation (GO:0070486) | 3.08583457 |
| 123 | cellular ketone body metabolic process (GO:0046950) | 3.08472690 |
| 124 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.08072118 |
| 125 | mitochondrial genome maintenance (GO:0000002) | 3.07874932 |
| 126 | T cell costimulation (GO:0031295) | 3.05590700 |
| 127 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.04996534 |
| 128 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.04881406 |
| 129 | T-helper cell differentiation (GO:0042093) | 3.04881406 |
| 130 | cell communication involved in cardiac conduction (GO:0086065) | 3.03701112 |
| 131 | startle response (GO:0001964) | 3.02957765 |
| 132 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.02855200 |
| 133 | sodium ion export (GO:0071436) | 3.02436293 |
| 134 | detection of bacterium (GO:0016045) | 3.02413026 |
| 135 | lymphocyte costimulation (GO:0031294) | 3.01579425 |
| 136 | detection of other organism (GO:0098543) | 3.00816390 |
| 137 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.99995302 |
| 138 | regulation of gamma-delta T cell activation (GO:0046643) | 2.99192412 |
| 139 | positive regulation of T cell cytokine production (GO:0002726) | 2.98632766 |
| 140 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.96820604 |
| 141 | cerebellar Purkinje cell layer development (GO:0021680) | 2.96728459 |
| 142 | neurotransmitter metabolic process (GO:0042133) | 2.95244531 |
| 143 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.94697480 |
| 144 | regulation of mast cell degranulation (GO:0043304) | 2.94020724 |
| 145 | succinate metabolic process (GO:0006105) | 2.93679684 |
| 146 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93295923 |
| 147 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93295923 |
| 148 | opioid receptor signaling pathway (GO:0038003) | 2.92613578 |
| 149 | purine ribonucleotide transport (GO:0015868) | 2.91694220 |
| 150 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.91455258 |
| 151 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.91400637 |
| 152 | oxidative phosphorylation (GO:0006119) | 2.90512025 |
| 153 | sulfation (GO:0051923) | 2.90121775 |
| 154 | regulation of T-helper 1 type immune response (GO:0002825) | 2.89212028 |
| 155 | neuron-neuron synaptic transmission (GO:0007270) | 2.89039396 |
| 156 | membrane hyperpolarization (GO:0060081) | 2.87065204 |
| 157 | positive thymic T cell selection (GO:0045059) | 2.87031018 |
| 158 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.86766277 |
| 159 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.84790982 |
| 160 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84579662 |
| 161 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.84514968 |
| 162 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.83385966 |
| 163 | regulation of relaxation of muscle (GO:1901077) | 2.83252847 |
| 164 | cellular response to interferon-gamma (GO:0071346) | 2.81279956 |
| 165 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.80498387 |
| 166 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.80395100 |
| 167 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.80395100 |
| 168 | neuron cell-cell adhesion (GO:0007158) | 2.80128427 |
| 169 | response to dietary excess (GO:0002021) | 2.80090438 |
| 170 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.78868352 |
| 171 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.78335411 |
| 172 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.77415257 |
| 173 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.77200809 |
| 174 | creatine metabolic process (GO:0006600) | 2.77183087 |
| 175 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.76164308 |
| 176 | positive regulation of cell killing (GO:0031343) | 2.75606700 |
| 177 | signal release (GO:0023061) | 2.75593327 |
| 178 | negative regulation of interleukin-2 production (GO:0032703) | 2.75569755 |
| 179 | positive regulation of interleukin-10 production (GO:0032733) | 2.74171788 |
| 180 | regulation of cell killing (GO:0031341) | 2.74049598 |
| 181 | vocalization behavior (GO:0071625) | 2.73474062 |
| 182 | regulation of tolerance induction (GO:0002643) | 2.71871443 |
| 183 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.71424570 |
| 184 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70509223 |
| 185 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.70300078 |
| 186 | T cell receptor signaling pathway (GO:0050852) | 2.69869660 |
| 187 | positive regulation of vesicle fusion (GO:0031340) | 2.69753801 |
| 188 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.69397622 |
| 189 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.69309869 |
| 190 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.69163218 |
| 191 | response to nerve growth factor (GO:1990089) | 2.69163218 |
| 192 | regulation of T cell tolerance induction (GO:0002664) | 2.67854352 |
| 193 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.66776734 |
| 194 | positive regulation of membrane potential (GO:0045838) | 2.63881223 |
| 195 | oxaloacetate metabolic process (GO:0006107) | 2.62591583 |
| 196 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.60161270 |
| 197 | positive regulation of action potential (GO:0045760) | 2.59799186 |
| 198 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.58947170 |
| 199 | reflex (GO:0060004) | 2.58565032 |
| 200 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.58407760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.30710078 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.16601455 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.67805090 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.54409238 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.31068206 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 4.08379655 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.04050051 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.79598758 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.46330542 |
| 10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.45695575 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.05832405 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.00125046 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.90015354 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.89607124 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.89607124 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.85614397 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.82096451 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.77123083 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.75228934 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74608076 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72456928 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.69444635 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68542902 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.67711921 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.62459801 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.62417970 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.60767155 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.59769200 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57864613 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.55181302 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51737984 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.47373767 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46317683 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44199555 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.43835382 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42729038 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.41003408 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.39030105 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.37780296 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.34925573 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.34785860 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.33662528 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.28832541 |
| 44 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21077693 |
| 45 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.17592756 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13037842 |
| 47 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08167029 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05628906 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05480543 |
| 50 | GATA3_26560356_Chip-Seq_TH2_Human | 2.02805842 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02689293 |
| 52 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02644869 |
| 53 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01483278 |
| 54 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98532185 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.95019419 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93172882 |
| 57 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.92010167 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.91564685 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90468478 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.88022851 |
| 61 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.85812455 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84940809 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.83338105 |
| 64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82149669 |
| 65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71686394 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.70314742 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68867570 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67721820 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.60391306 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52570305 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.50198445 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50043551 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45065353 |
| 74 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.42738187 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.41699147 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41556757 |
| 77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39422151 |
| 78 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39026862 |
| 79 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36718685 |
| 80 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35751321 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.31148317 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30672988 |
| 83 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30302940 |
| 84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29963061 |
| 85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.29509565 |
| 86 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28779679 |
| 87 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28317272 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26089072 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25852428 |
| 90 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25272669 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23520428 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22865999 |
| 93 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.22775312 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22597232 |
| 95 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21689211 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21379411 |
| 97 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.20846587 |
| 98 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20819169 |
| 99 | MAF_26560356_Chip-Seq_TH1_Human | 1.20224172 |
| 100 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19120894 |
| 101 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18412590 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16651894 |
| 103 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16124322 |
| 104 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15901038 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15624381 |
| 106 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15069779 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14895713 |
| 108 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14767500 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14434721 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13234213 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13060317 |
| 112 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.11424644 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09377456 |
| 114 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08975408 |
| 115 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08261615 |
| 116 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08170821 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08131562 |
| 118 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07817329 |
| 119 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07350462 |
| 120 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07292739 |
| 121 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06832189 |
| 122 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06742158 |
| 123 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06185466 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.03317105 |
| 125 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03292701 |
| 126 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03094763 |
| 127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02653298 |
| 128 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02317393 |
| 129 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00439335 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00400316 |
| 131 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99945439 |
| 132 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98897268 |
| 133 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98797354 |
| 134 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98410324 |
| 135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98230819 |
| 136 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97890550 |
| 137 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97537987 |
| 138 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96313285 |
| 139 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96031078 |
| 140 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.94539406 |
| 141 | MAF_26560356_Chip-Seq_TH2_Human | 0.94296839 |
| 142 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94104758 |
| 143 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94078856 |
| 144 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.93769348 |
| 145 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92960582 |
| 146 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.92780055 |
| 147 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.92286148 |
| 148 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91686062 |
| 149 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91602650 |
| 150 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91342415 |
| 151 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91333056 |
| 152 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.91141349 |
| 153 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.90589587 |
| 154 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90572162 |
| 155 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90516774 |
| 156 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89815333 |
| 157 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89788440 |
| 158 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89371116 |
| 159 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88937770 |
| 160 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87197248 |
| 161 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87171885 |
| 162 | FUS_26573619_Chip-Seq_HEK293_Human | 0.86942691 |
| 163 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.86486971 |
| 164 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86408071 |
| 165 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86210636 |
| 166 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86161224 |
| 167 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86116513 |
| 168 | GATA3_26560356_Chip-Seq_TH1_Human | 0.85938429 |
| 169 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85604832 |
| 170 | STAT3_23295773_ChIP-Seq_U87_Human | 0.85333239 |
| 171 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84836529 |
| 172 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.84552187 |
| 173 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.82228342 |
| 174 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.81145839 |
| 175 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.81081632 |
| 176 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.80984449 |
| 177 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.80969817 |
| 178 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.80611607 |
| 179 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.80335780 |
| 180 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.79566678 |
| 181 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79224017 |
| 182 | AR_19668381_ChIP-Seq_PC3_Human | 0.79105515 |
| 183 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.78601028 |
| 184 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.77848071 |
| 185 | VDR_22108803_ChIP-Seq_LS180_Human | 0.77666187 |
| 186 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77547553 |
| 187 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.77430547 |
| 188 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77271531 |
| 189 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.76812860 |
| 190 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.76790609 |
| 191 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.76737186 |
| 192 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.76703510 |
| 193 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75771380 |
| 194 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.75289032 |
| 195 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.73615939 |
| 196 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.73391717 |
| 197 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.72973085 |
| 198 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72681263 |
| 199 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.72568010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.69905244 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.27207659 |
| 3 | MP0003724_increased_susceptibility_to | 4.19086781 |
| 4 | MP0005671_abnormal_response_to | 4.04656128 |
| 5 | MP0003303_peritoneal_inflammation | 3.63491841 |
| 6 | MP0004142_abnormal_muscle_tone | 3.51466397 |
| 7 | MP0009046_muscle_twitch | 3.48770456 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 3.36065379 |
| 9 | MP0002332_abnormal_exercise_endurance | 3.35874026 |
| 10 | MP0003880_abnormal_central_pattern | 3.27597367 |
| 11 | MP0001800_abnormal_humoral_immune | 3.15675476 |
| 12 | MP0005387_immune_system_phenotype | 3.14536790 |
| 13 | MP0001790_abnormal_immune_system | 3.14536790 |
| 14 | MP0000751_myopathy | 3.11312686 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.92869606 |
| 16 | MP0002064_seizures | 2.85068195 |
| 17 | MP0009745_abnormal_behavioral_response | 2.76086281 |
| 18 | MP0006082_CNS_inflammation | 2.74435402 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.68722329 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 2.68015956 |
| 21 | MP0001853_heart_inflammation | 2.67569662 |
| 22 | MP0009785_altered_susceptibility_to | 2.64608827 |
| 23 | MP0002723_abnormal_immune_serum | 2.59829561 |
| 24 | MP0002234_abnormal_pharynx_morphology | 2.57207220 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.54719896 |
| 26 | MP0000685_abnormal_immune_system | 2.52919881 |
| 27 | MP0003436_decreased_susceptibility_to | 2.52300929 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 2.44236061 |
| 29 | MP0002272_abnormal_nervous_system | 2.38727062 |
| 30 | MP0002420_abnormal_adaptive_immunity | 2.36962269 |
| 31 | MP0002184_abnormal_innervation | 2.35920402 |
| 32 | MP0001819_abnormal_immune_cell | 2.34254415 |
| 33 | MP0002419_abnormal_innate_immunity | 2.32693130 |
| 34 | MP0004381_abnormal_hair_follicle | 2.29682630 |
| 35 | MP0002063_abnormal_learning/memory/cond | 2.28681600 |
| 36 | MP0004036_abnormal_muscle_relaxation | 2.28084944 |
| 37 | MP0005025_abnormal_response_to | 2.25490226 |
| 38 | MP0000955_abnormal_spinal_cord | 2.25189061 |
| 39 | MP0003763_abnormal_thymus_physiology | 2.17554526 |
| 40 | MP0004484_altered_response_of | 2.10897625 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 2.10012661 |
| 42 | MP0002269_muscular_atrophy | 2.07514768 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 2.07328933 |
| 44 | MP0004270_analgesia | 2.04534084 |
| 45 | MP0001486_abnormal_startle_reflex | 2.03608631 |
| 46 | MP0004215_abnormal_myocardial_fiber | 2.03544043 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.92767644 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.88016455 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.84049618 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.83945193 |
| 51 | MP0002405_respiratory_system_inflammati | 1.80434053 |
| 52 | MP0005085_abnormal_gallbladder_physiolo | 1.79355296 |
| 53 | MP0000372_irregular_coat_pigmentation | 1.78083803 |
| 54 | MP0002398_abnormal_bone_marrow | 1.76351241 |
| 55 | MP0008569_lethality_at_weaning | 1.74400497 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.72853053 |
| 57 | MP0000716_abnormal_immune_system | 1.72562999 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.70690665 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.69781214 |
| 60 | MP0002254_reproductive_system_inflammat | 1.69620857 |
| 61 | MP0009764_decreased_sensitivity_to | 1.68154968 |
| 62 | MP0002572_abnormal_emotion/affect_behav | 1.66972749 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.66301476 |
| 64 | MP0001970_abnormal_pain_threshold | 1.65196185 |
| 65 | MP0002909_abnormal_adrenal_gland | 1.62664677 |
| 66 | MP0001529_abnormal_vocalization | 1.56561467 |
| 67 | MP0002736_abnormal_nociception_after | 1.56245624 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 1.55203149 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.52631677 |
| 70 | MP0001873_stomach_inflammation | 1.47361428 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.47014811 |
| 72 | MP0003329_amyloid_beta_deposits | 1.47009752 |
| 73 | MP0000689_abnormal_spleen_morphology | 1.46717067 |
| 74 | MP0005423_abnormal_somatic_nervous | 1.46709858 |
| 75 | MP0005310_abnormal_salivary_gland | 1.46698698 |
| 76 | MP0003866_abnormal_defecation | 1.46465788 |
| 77 | MP0002882_abnormal_neuron_morphology | 1.45533949 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.42643792 |
| 79 | MP0004510_myositis | 1.41452497 |
| 80 | MP0008469_abnormal_protein_level | 1.39664808 |
| 81 | MP0002429_abnormal_blood_cell | 1.39562882 |
| 82 | MP0000566_synostosis | 1.39527390 |
| 83 | MP0002006_tumorigenesis | 1.39392414 |
| 84 | MP0000569_abnormal_digit_pigmentation | 1.39128692 |
| 85 | MP0003879_abnormal_hair_cell | 1.37474708 |
| 86 | MP0004811_abnormal_neuron_physiology | 1.37223772 |
| 87 | MP0002229_neurodegeneration | 1.35097088 |
| 88 | MP0001851_eye_inflammation | 1.34503057 |
| 89 | MP0001533_abnormal_skeleton_physiology | 1.34427928 |
| 90 | MP0005266_abnormal_metabolism | 1.33548269 |
| 91 | MP0003075_altered_response_to | 1.32253583 |
| 92 | MP0004947_skin_inflammation | 1.30647002 |
| 93 | MP0005623_abnormal_meninges_morphology | 1.30550392 |
| 94 | MP0002557_abnormal_social/conspecific_i | 1.30007999 |
| 95 | MP0000015_abnormal_ear_pigmentation | 1.28962167 |
| 96 | MP0000759_abnormal_skeletal_muscle | 1.28934092 |
| 97 | MP0001501_abnormal_sleep_pattern | 1.28748974 |
| 98 | MP0004233_abnormal_muscle_weight | 1.28461560 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 1.26875941 |
| 100 | MP0002733_abnormal_thermal_nociception | 1.26311739 |
| 101 | MP0002722_abnormal_immune_system | 1.25641743 |
| 102 | MP0008875_abnormal_xenobiotic_pharmacok | 1.23423579 |
| 103 | MP0001440_abnormal_grooming_behavior | 1.23146676 |
| 104 | MP0005174_abnormal_tail_pigmentation | 1.22315082 |
| 105 | MP0002277_abnormal_respiratory_mucosa | 1.21513501 |
| 106 | MP0000749_muscle_degeneration | 1.20782922 |
| 107 | MP0002752_abnormal_somatic_nervous | 1.18991425 |
| 108 | MP0005386_behavior/neurological_phenoty | 1.18983379 |
| 109 | MP0004924_abnormal_behavior | 1.18983379 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 1.18465077 |
| 111 | MP0002139_abnormal_hepatobiliary_system | 1.18410913 |
| 112 | MP0002090_abnormal_vision | 1.17568088 |
| 113 | MP0005166_decreased_susceptibility_to | 1.16544523 |
| 114 | MP0005394_taste/olfaction_phenotype | 1.14355625 |
| 115 | MP0005499_abnormal_olfactory_system | 1.14355625 |
| 116 | MP0001984_abnormal_olfaction | 1.13799835 |
| 117 | MP0005360_urolithiasis | 1.13518117 |
| 118 | MP0006276_abnormal_autonomic_nervous | 1.13216970 |
| 119 | MP0002132_abnormal_respiratory_system | 1.12144480 |
| 120 | MP0000778_abnormal_nervous_system | 1.10736555 |
| 121 | MP0000703_abnormal_thymus_morphology | 1.10646297 |
| 122 | MP0002102_abnormal_ear_morphology | 1.08935623 |
| 123 | MP0002972_abnormal_cardiac_muscle | 1.07787078 |
| 124 | MP0004085_abnormal_heartbeat | 1.06413667 |
| 125 | MP0001177_atelectasis | 1.04728436 |
| 126 | MP0002396_abnormal_hematopoietic_system | 1.04033414 |
| 127 | MP0002163_abnormal_gland_morphology | 1.03972355 |
| 128 | MP0001502_abnormal_circadian_rhythm | 1.03507702 |
| 129 | MP0003633_abnormal_nervous_system | 1.03107949 |
| 130 | MP0005620_abnormal_muscle_contractility | 1.02365597 |
| 131 | MP0003300_gastrointestinal_ulcer | 0.98954996 |
| 132 | MP0009763_increased_sensitivity_to | 0.97288460 |
| 133 | MP0000747_muscle_weakness | 0.95494451 |
| 134 | MP0002138_abnormal_hepatobiliary_system | 0.94711242 |
| 135 | MP0005379_endocrine/exocrine_gland_phen | 0.93754388 |
| 136 | MP0001963_abnormal_hearing_physiology | 0.92968271 |
| 137 | MP0005367_renal/urinary_system_phenotyp | 0.91815998 |
| 138 | MP0000516_abnormal_urinary_system | 0.91815998 |
| 139 | MP0008775_abnormal_heart_ventricle | 0.91635586 |
| 140 | MP0008877_abnormal_DNA_methylation | 0.91469500 |
| 141 | MP0000858_altered_metastatic_potential | 0.90937212 |
| 142 | MP0004087_abnormal_muscle_fiber | 0.88450671 |
| 143 | MP0003787_abnormal_imprinting | 0.87918718 |
| 144 | MP0001663_abnormal_digestive_system | 0.87488627 |
| 145 | MP0003646_muscle_fatigue | 0.87238715 |
| 146 | MP0005397_hematopoietic_system_phenotyp | 0.87066789 |
| 147 | MP0001545_abnormal_hematopoietic_system | 0.87066789 |
| 148 | MP0008260_abnormal_autophagy | 0.86552023 |
| 149 | MP0000343_altered_response_to | 0.86152695 |
| 150 | MP0002876_abnormal_thyroid_physiology | 0.84254567 |
| 151 | MP0010329_abnormal_lipoprotein_level | 0.84118679 |
| 152 | MP0005451_abnormal_body_composition | 0.84004391 |
| 153 | MP0003122_maternal_imprinting | 0.83081365 |
| 154 | MP0006035_abnormal_mitochondrial_morpho | 0.82235195 |
| 155 | MP0000920_abnormal_myelination | 0.82058117 |
| 156 | MP0002796_impaired_skin_barrier | 0.81845438 |
| 157 | MP0003195_calcinosis | 0.81232436 |
| 158 | MP0003806_abnormal_nucleotide_metabolis | 0.81223441 |
| 159 | MP0005330_cardiomyopathy | 0.80198649 |
| 160 | MP0003252_abnormal_bile_duct | 0.80002405 |
| 161 | MP0003631_nervous_system_phenotype | 0.79558359 |
| 162 | MP0004043_abnormal_pH_regulation | 0.79490818 |
| 163 | MP0004858_abnormal_nervous_system | 0.78885987 |
| 164 | MP0002933_joint_inflammation | 0.77820285 |
| 165 | MP0003868_abnormal_feces_composition | 0.75501703 |
| 166 | MP0009840_abnormal_foam_cell | 0.73649470 |
| 167 | MP0004130_abnormal_muscle_cell | 0.73520902 |
| 168 | MP0003634_abnormal_glial_cell | 0.73403325 |
| 169 | MP0003137_abnormal_impulse_conducting | 0.73134072 |
| 170 | MP0001943_abnormal_respiration | 0.73025868 |
| 171 | MP0003948_abnormal_gas_homeostasis | 0.72866232 |
| 172 | MP0002693_abnormal_pancreas_physiology | 0.71997730 |
| 173 | MP0000534_abnormal_ureter_morphology | 0.71766808 |
| 174 | MP0006138_congestive_heart_failure | 0.71242021 |
| 175 | MP0008874_decreased_physiological_sensi | 0.71228594 |
| 176 | MP0001881_abnormal_mammary_gland | 0.70525869 |
| 177 | MP0002998_abnormal_bone_remodeling | 0.70214726 |
| 178 | MP0000609_abnormal_liver_physiology | 0.70188893 |
| 179 | MP0003448_altered_tumor_morphology | 0.68965177 |
| 180 | MP0001905_abnormal_dopamine_level | 0.67918286 |
| 181 | MP0001544_abnormal_cardiovascular_syste | 0.67121697 |
| 182 | MP0005535_abnormal_body_temperature | 0.66964839 |
| 183 | MP0003828_pulmonary_edema | 0.65146837 |
| 184 | MP0003453_abnormal_keratinocyte_physiol | 0.62092593 |
| 185 | MP0001919_abnormal_reproductive_system | 0.59853422 |
| 186 | MP0002095_abnormal_skin_pigmentation | 0.57496529 |
| 187 | MP0005410_abnormal_fertilization | 0.55919718 |
| 188 | MP0002136_abnormal_kidney_physiology | 0.55528747 |
| 189 | MP0000249_abnormal_blood_vessel | 0.53453523 |
| 190 | MP0005058_abnormal_lysosome_morphology | 0.52116070 |
| 191 | MP0005332_abnormal_amino_acid | 0.50899014 |
| 192 | MP0005365_abnormal_bile_salt | 0.50805919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.79653382 |
| 2 | 3-Methylglutaconic aciduria (HP:0003535) | 4.55288319 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 4.26156256 |
| 4 | Abnormality of the vocal cords (HP:0008777) | 4.17959965 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.99360553 |
| 6 | Megalencephaly (HP:0001355) | 3.97829647 |
| 7 | Pheochromocytoma (HP:0002666) | 3.97812776 |
| 8 | Progressive macrocephaly (HP:0004481) | 3.93787944 |
| 9 | Stomatitis (HP:0010280) | 3.93546427 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86675473 |
| 11 | Absence seizures (HP:0002121) | 3.84879939 |
| 12 | Acute encephalopathy (HP:0006846) | 3.73240885 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.69761629 |
| 14 | Mitochondrial inheritance (HP:0001427) | 3.64568130 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.63976093 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.61758886 |
| 17 | Atonic seizures (HP:0010819) | 3.59820678 |
| 18 | T lymphocytopenia (HP:0005403) | 3.59485671 |
| 19 | Myositis (HP:0100614) | 3.57229809 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.47486592 |
| 21 | Neuroendocrine neoplasm (HP:0100634) | 3.44803198 |
| 22 | Pulmonary infiltrates (HP:0002113) | 3.44323334 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.40507773 |
| 24 | Optic neuritis (HP:0100653) | 3.40507773 |
| 25 | Focal motor seizures (HP:0011153) | 3.31609918 |
| 26 | Abnormality of T cell number (HP:0011839) | 3.30808354 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.30172919 |
| 28 | Febrile seizures (HP:0002373) | 3.29877377 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.26174028 |
| 30 | Obstructive lung disease (HP:0006536) | 3.26174028 |
| 31 | Hepatocellular necrosis (HP:0001404) | 3.24526562 |
| 32 | Progressive external ophthalmoplegia (HP:0000590) | 3.16090546 |
| 33 | Cerebral edema (HP:0002181) | 3.08860616 |
| 34 | Dialeptic seizures (HP:0011146) | 3.08787246 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.07119671 |
| 36 | Epileptic encephalopathy (HP:0200134) | 3.06437058 |
| 37 | Conjunctival hamartoma (HP:0100780) | 3.06358747 |
| 38 | Abnormality of macrophages (HP:0004311) | 3.03543338 |
| 39 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.02294410 |
| 40 | Orchitis (HP:0100796) | 3.00318186 |
| 41 | Hepatic necrosis (HP:0002605) | 2.99913583 |
| 42 | Exercise-induced myalgia (HP:0003738) | 2.96637613 |
| 43 | Eczematoid dermatitis (HP:0000976) | 2.95061404 |
| 44 | Ketoacidosis (HP:0001993) | 2.92755964 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.91300763 |
| 46 | Palpitations (HP:0001962) | 2.90259330 |
| 47 | Vasculitis (HP:0002633) | 2.90227645 |
| 48 | Muscle stiffness (HP:0003552) | 2.90044134 |
| 49 | Increased CSF lactate (HP:0002490) | 2.89778967 |
| 50 | Petechiae (HP:0000967) | 2.88514739 |
| 51 | Dysdiadochokinesis (HP:0002075) | 2.87020819 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.86099526 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.86099526 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.86099526 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.84068952 |
| 56 | Hypoproteinemia (HP:0003075) | 2.83346083 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81227072 |
| 58 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81227072 |
| 59 | Anxiety (HP:0000739) | 2.77701359 |
| 60 | Cerebellar dysplasia (HP:0007033) | 2.77291784 |
| 61 | Increased intramyocellular lipid droplets (HP:0012240) | 2.76657327 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76344091 |
| 63 | Spastic paraparesis (HP:0002313) | 2.75185750 |
| 64 | IgG deficiency (HP:0004315) | 2.73863129 |
| 65 | Episodic fever (HP:0001954) | 2.72085849 |
| 66 | Meningitis (HP:0001287) | 2.71720989 |
| 67 | Encephalitis (HP:0002383) | 2.70424111 |
| 68 | Poor suck (HP:0002033) | 2.69595090 |
| 69 | Alveolar cell carcinoma (HP:0006519) | 2.67115427 |
| 70 | Gastrointestinal infarctions (HP:0005244) | 2.64487595 |
| 71 | Congenital, generalized hypertrichosis (HP:0004540) | 2.64426044 |
| 72 | Severe combined immunodeficiency (HP:0004430) | 2.63635688 |
| 73 | Focal seizures (HP:0007359) | 2.61020144 |
| 74 | Sex reversal (HP:0012245) | 2.58576375 |
| 75 | Abnormal sex determination (HP:0012244) | 2.58576375 |
| 76 | Slow saccadic eye movements (HP:0000514) | 2.58406114 |
| 77 | Abnormality of T cells (HP:0002843) | 2.57482015 |
| 78 | Bundle branch block (HP:0011710) | 2.56805668 |
| 79 | Progressive cerebellar ataxia (HP:0002073) | 2.56667459 |
| 80 | Emotional lability (HP:0000712) | 2.55249489 |
| 81 | Hemoptysis (HP:0002105) | 2.53070557 |
| 82 | Recurrent skin infections (HP:0001581) | 2.51181855 |
| 83 | Optic disc pallor (HP:0000543) | 2.51178354 |
| 84 | Abnormality of the aortic arch (HP:0012303) | 2.51099824 |
| 85 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.50677281 |
| 86 | Increased muscle lipid content (HP:0009058) | 2.48873440 |
| 87 | Chronic diarrhea (HP:0002028) | 2.48784148 |
| 88 | Leukodystrophy (HP:0002415) | 2.48747323 |
| 89 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.46033445 |
| 90 | Sudden death (HP:0001699) | 2.45922932 |
| 91 | Exercise intolerance (HP:0003546) | 2.44810519 |
| 92 | Ventricular fibrillation (HP:0001663) | 2.44782596 |
| 93 | Adenoma sebaceum (HP:0009720) | 2.43894616 |
| 94 | Angiofibromas (HP:0010615) | 2.43894616 |
| 95 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.43201749 |
| 96 | Atrial fibrillation (HP:0005110) | 2.41903396 |
| 97 | Respiratory failure (HP:0002878) | 2.40857615 |
| 98 | Chest pain (HP:0100749) | 2.40854156 |
| 99 | Depression (HP:0000716) | 2.40834440 |
| 100 | Action tremor (HP:0002345) | 2.40808665 |
| 101 | Gangrene (HP:0100758) | 2.39615848 |
| 102 | Keratoconjunctivitis (HP:0001096) | 2.38738392 |
| 103 | Autoimmune hemolytic anemia (HP:0001890) | 2.37115147 |
| 104 | Renal Fanconi syndrome (HP:0001994) | 2.36640880 |
| 105 | Keratoconjunctivitis sicca (HP:0001097) | 2.34936079 |
| 106 | Anhidrosis (HP:0000970) | 2.34050696 |
| 107 | Sensorimotor neuropathy (HP:0007141) | 2.33708243 |
| 108 | Pulmonary embolism (HP:0002204) | 2.33073943 |
| 109 | Abnormality of the prostate (HP:0008775) | 2.32435372 |
| 110 | Dysmetria (HP:0001310) | 2.32287273 |
| 111 | Limb-girdle muscle atrophy (HP:0003797) | 2.31497571 |
| 112 | Orthostatic hypotension (HP:0001278) | 2.30337615 |
| 113 | Ketosis (HP:0001946) | 2.29548957 |
| 114 | Ulnar claw (HP:0001178) | 2.28258146 |
| 115 | Partial agenesis of the corpus callosum (HP:0001338) | 2.26767894 |
| 116 | Skin nodule (HP:0200036) | 2.26443563 |
| 117 | Cerebral hemorrhage (HP:0001342) | 2.26319788 |
| 118 | Recurrent bronchitis (HP:0002837) | 2.26172750 |
| 119 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.22775419 |
| 120 | Abnormality of alanine metabolism (HP:0010916) | 2.22775419 |
| 121 | Hyperalaninemia (HP:0003348) | 2.22775419 |
| 122 | Primary atrial arrhythmia (HP:0001692) | 2.21762050 |
| 123 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21012989 |
| 124 | Gingival bleeding (HP:0000225) | 2.20936623 |
| 125 | Panhypogammaglobulinemia (HP:0003139) | 2.20734367 |
| 126 | Increased serum pyruvate (HP:0003542) | 2.18909427 |
| 127 | Abnormality of glycolysis (HP:0004366) | 2.18909427 |
| 128 | Microretrognathia (HP:0000308) | 2.18228010 |
| 129 | Exertional dyspnea (HP:0002875) | 2.18077059 |
| 130 | Supraventricular tachycardia (HP:0004755) | 2.15204258 |
| 131 | Lactic acidosis (HP:0003128) | 2.14951153 |
| 132 | Thyroiditis (HP:0100646) | 2.13795041 |
| 133 | Combined immunodeficiency (HP:0005387) | 2.13600668 |
| 134 | Arterial thrombosis (HP:0004420) | 2.13352977 |
| 135 | Abnormal EKG (HP:0003115) | 2.12160286 |
| 136 | Abnormality of the pleura (HP:0002103) | 2.10998644 |
| 137 | Epistaxis (HP:0000421) | 2.10454825 |
| 138 | Hamartoma of the eye (HP:0010568) | 2.10322725 |
| 139 | Prolonged bleeding time (HP:0003010) | 2.10027547 |
| 140 | Epileptiform EEG discharges (HP:0011182) | 2.09817853 |
| 141 | Increased hepatocellular lipid droplets (HP:0006565) | 2.09067147 |
| 142 | Gonadal dysgenesis (HP:0000133) | 2.08324074 |
| 143 | Supraventricular arrhythmia (HP:0005115) | 2.08028916 |
| 144 | Torticollis (HP:0000473) | 2.07897328 |
| 145 | Pulmonary fibrosis (HP:0002206) | 2.07790990 |
| 146 | Abnormal spermatogenesis (HP:0008669) | 2.07191184 |
| 147 | Urticaria (HP:0001025) | 2.06587319 |
| 148 | Athetosis (HP:0002305) | 2.05863490 |
| 149 | Paraparesis (HP:0002385) | 2.05689547 |
| 150 | Anorexia (HP:0002039) | 2.04202943 |
| 151 | Syncope (HP:0001279) | 2.04129888 |
| 152 | Recurrent viral infections (HP:0004429) | 2.03892760 |
| 153 | Ankle clonus (HP:0011448) | 2.03840407 |
| 154 | Porencephaly (HP:0002132) | 2.02713209 |
| 155 | Abnormality of the axillary hair (HP:0100134) | 2.02619604 |
| 156 | Abnormality of secondary sexual hair (HP:0009888) | 2.02619604 |
| 157 | Increased CSF protein (HP:0002922) | 2.02547934 |
| 158 | Visual hallucinations (HP:0002367) | 2.01558118 |
| 159 | Inflammation of the large intestine (HP:0002037) | 2.00697394 |
| 160 | Amblyopia (HP:0000646) | 2.00303829 |
| 161 | Joint swelling (HP:0001386) | 2.00212949 |
| 162 | EEG with generalized epileptiform discharges (HP:0011198) | 2.00182707 |
| 163 | Lipid accumulation in hepatocytes (HP:0006561) | 1.99776551 |
| 164 | Status epilepticus (HP:0002133) | 1.98225777 |
| 165 | Foot dorsiflexor weakness (HP:0009027) | 1.97851150 |
| 166 | Global brain atrophy (HP:0002283) | 1.96925458 |
| 167 | Hypothermia (HP:0002045) | 1.96881229 |
| 168 | Arthropathy (HP:0003040) | 1.96804264 |
| 169 | Prolonged QT interval (HP:0001657) | 1.95607264 |
| 170 | IgM deficiency (HP:0002850) | 1.94837390 |
| 171 | Keratitis (HP:0000491) | 1.94824339 |
| 172 | Focal dystonia (HP:0004373) | 1.94248778 |
| 173 | Albinism (HP:0001022) | 1.93631565 |
| 174 | Micronodular cirrhosis (HP:0001413) | 1.91208104 |
| 175 | Exercise-induced muscle cramps (HP:0003710) | 1.89522559 |
| 176 | Cholelithiasis (HP:0001081) | 1.89046548 |
| 177 | Craniofacial dystonia (HP:0012179) | 1.87921470 |
| 178 | Dysmetric saccades (HP:0000641) | 1.87543954 |
| 179 | Urinary urgency (HP:0000012) | 1.86953149 |
| 180 | Asymmetric septal hypertrophy (HP:0001670) | 1.86768202 |
| 181 | EMG: myopathic abnormalities (HP:0003458) | 1.85877336 |
| 182 | Abnormality of the foot musculature (HP:0001436) | 1.85388724 |
| 183 | Slow progression (HP:0003677) | 1.82919204 |
| 184 | Abnormality of the calf musculature (HP:0001430) | 1.82877521 |
| 185 | Abnormal gallbladder morphology (HP:0012437) | 1.81988853 |
| 186 | Hypercortisolism (HP:0001578) | 1.81046718 |
| 187 | Myotonia (HP:0002486) | 1.80081923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 6.90547635 |
| 2 | BMPR2 | 4.81951040 |
| 3 | IRAK3 | 4.41781758 |
| 4 | MINK1 | 3.65280271 |
| 5 | MATK | 3.55593552 |
| 6 | NEK1 | 3.22767963 |
| 7 | RIPK4 | 3.16467108 |
| 8 | MAP4K1 | 3.16163092 |
| 9 | TAOK1 | 3.11496338 |
| 10 | MAP3K12 | 3.01961925 |
| 11 | TAOK2 | 2.98438147 |
| 12 | MARK1 | 2.75439732 |
| 13 | MAP3K3 | 2.52628363 |
| 14 | MAP3K9 | 2.48547033 |
| 15 | PAK6 | 2.34203739 |
| 16 | MAP2K3 | 2.27676162 |
| 17 | MAPKAPK3 | 2.21891525 |
| 18 | TAOK3 | 2.17728089 |
| 19 | CSK | 2.13421282 |
| 20 | LMTK2 | 2.12659375 |
| 21 | TXK | 2.11586189 |
| 22 | NLK | 2.07738981 |
| 23 | PAK3 | 2.01301832 |
| 24 | KSR2 | 1.98555927 |
| 25 | MAP3K4 | 1.86302446 |
| 26 | PHKG2 | 1.80837331 |
| 27 | PHKG1 | 1.80837331 |
| 28 | MAP2K7 | 1.79711284 |
| 29 | BLK | 1.79401115 |
| 30 | MAP2K4 | 1.76781320 |
| 31 | PKN2 | 1.72826197 |
| 32 | KIT | 1.69447280 |
| 33 | NTRK3 | 1.67081287 |
| 34 | LIMK1 | 1.66996381 |
| 35 | CDK19 | 1.66921424 |
| 36 | PRPF4B | 1.62352644 |
| 37 | GRK6 | 1.58990809 |
| 38 | NME1 | 1.58793358 |
| 39 | MAP3K14 | 1.55935884 |
| 40 | FRK | 1.53743839 |
| 41 | CSF1R | 1.51636836 |
| 42 | IKBKB | 1.49575591 |
| 43 | EPHA4 | 1.47692713 |
| 44 | CAMK2D | 1.47274434 |
| 45 | BTK | 1.45787132 |
| 46 | TLK1 | 1.44825942 |
| 47 | MAP3K13 | 1.41676188 |
| 48 | LYN | 1.40794305 |
| 49 | CAMK2G | 1.40794124 |
| 50 | NTRK1 | 1.40251794 |
| 51 | GRK7 | 1.36866272 |
| 52 | LCK | 1.34931181 |
| 53 | ZAP70 | 1.33530154 |
| 54 | JAK3 | 1.32890873 |
| 55 | NUAK1 | 1.32174348 |
| 56 | MAP3K11 | 1.31321570 |
| 57 | MAP3K5 | 1.29383117 |
| 58 | SYK | 1.29099127 |
| 59 | TYK2 | 1.28931354 |
| 60 | TEC | 1.27141173 |
| 61 | JAK1 | 1.25791789 |
| 62 | HCK | 1.24815002 |
| 63 | ITK | 1.24593212 |
| 64 | NTRK2 | 1.18718101 |
| 65 | WNK1 | 1.18250344 |
| 66 | IRAK2 | 1.15886609 |
| 67 | BCKDK | 1.10668727 |
| 68 | KSR1 | 1.10348630 |
| 69 | LATS2 | 1.07251197 |
| 70 | CAMKK1 | 1.05765297 |
| 71 | TTN | 1.05370869 |
| 72 | PINK1 | 1.02972435 |
| 73 | CSNK1G3 | 1.02721577 |
| 74 | MARK3 | 1.00583240 |
| 75 | MYLK | 1.00005833 |
| 76 | CSNK1A1L | 0.99771132 |
| 77 | PRKD3 | 0.99591937 |
| 78 | CAMK2A | 0.97143101 |
| 79 | PRKCG | 0.94324232 |
| 80 | CAMK2B | 0.89656673 |
| 81 | IKBKE | 0.88933713 |
| 82 | MAPK13 | 0.88930130 |
| 83 | GRK5 | 0.88586227 |
| 84 | ROCK2 | 0.85632307 |
| 85 | CSNK1G2 | 0.84217841 |
| 86 | CDK5 | 0.83894387 |
| 87 | IRAK1 | 0.83655455 |
| 88 | ARAF | 0.82757902 |
| 89 | FES | 0.82754935 |
| 90 | STK39 | 0.81318535 |
| 91 | TRIB3 | 0.81117913 |
| 92 | SIK3 | 0.80436113 |
| 93 | FER | 0.79461341 |
| 94 | STK38 | 0.78450391 |
| 95 | PLK2 | 0.74831814 |
| 96 | OBSCN | 0.73010424 |
| 97 | ALK | 0.72751161 |
| 98 | OXSR1 | 0.69394029 |
| 99 | PDPK1 | 0.67938007 |
| 100 | NME2 | 0.67542118 |
| 101 | CSNK1G1 | 0.67104522 |
| 102 | PRKCQ | 0.66851345 |
| 103 | TRPM7 | 0.65528428 |
| 104 | WNK4 | 0.65357307 |
| 105 | PDK1 | 0.64152759 |
| 106 | CDK14 | 0.63615632 |
| 107 | MAP2K1 | 0.62728073 |
| 108 | ADRBK2 | 0.60347736 |
| 109 | CDC42BPA | 0.60236082 |
| 110 | PRKCE | 0.60088526 |
| 111 | PRKG2 | 0.59976030 |
| 112 | PRKCZ | 0.58115494 |
| 113 | IRAK4 | 0.57258851 |
| 114 | RET | 0.57040861 |
| 115 | ERBB3 | 0.56265305 |
| 116 | TBK1 | 0.55279518 |
| 117 | YES1 | 0.54664270 |
| 118 | STK10 | 0.52713772 |
| 119 | UHMK1 | 0.52321691 |
| 120 | CAMK1D | 0.52084347 |
| 121 | MST4 | 0.51473657 |
| 122 | MAPKAPK2 | 0.51337238 |
| 123 | CDK15 | 0.49996024 |
| 124 | DAPK3 | 0.49027856 |
| 125 | MAP3K1 | 0.48790866 |
| 126 | DAPK2 | 0.48332500 |
| 127 | CDK18 | 0.48235564 |
| 128 | PIK3CG | 0.47956162 |
| 129 | PRKCH | 0.47870572 |
| 130 | IGF1R | 0.47192340 |
| 131 | CHUK | 0.46404312 |
| 132 | TNK2 | 0.43357175 |
| 133 | JAK2 | 0.42706806 |
| 134 | PTK2B | 0.42377299 |
| 135 | FYN | 0.42079051 |
| 136 | CAMK4 | 0.40220433 |
| 137 | ABL1 | 0.40177021 |
| 138 | GRK1 | 0.39466577 |
| 139 | ADRBK1 | 0.37669734 |
| 140 | CDK11A | 0.37615148 |
| 141 | ILK | 0.36641507 |
| 142 | SGK223 | 0.35774273 |
| 143 | SGK494 | 0.35774273 |
| 144 | ERBB2 | 0.35596563 |
| 145 | PKN1 | 0.35371457 |
| 146 | PRKACA | 0.34843660 |
| 147 | CAMK1 | 0.34828342 |
| 148 | MST1R | 0.34802891 |
| 149 | CAMK1G | 0.34361772 |
| 150 | PIM1 | 0.33241804 |
| 151 | PRKACB | 0.33024679 |
| 152 | EGFR | 0.32435879 |
| 153 | MOS | 0.32190706 |
| 154 | CAMKK2 | 0.31446979 |
| 155 | RIPK1 | 0.31060621 |
| 156 | DYRK1A | 0.30297007 |
| 157 | DAPK1 | 0.30123183 |
| 158 | FGR | 0.29149112 |
| 159 | MUSK | 0.28989796 |
| 160 | SCYL2 | 0.28463318 |
| 161 | RAF1 | 0.28049735 |
| 162 | MAP3K6 | 0.27457011 |
| 163 | PRKACG | 0.27089849 |
| 164 | LRRK2 | 0.26594106 |
| 165 | WNK3 | 0.26399797 |
| 166 | PRKCA | 0.26190606 |
| 167 | CSNK1E | 0.25384041 |
| 168 | ERBB4 | 0.25268848 |
| 169 | MAP2K6 | 0.22609428 |
| 170 | FLT3 | 0.22189663 |
| 171 | PRKG1 | 0.21875085 |
| 172 | INSR | 0.19559761 |
| 173 | CSNK2A1 | 0.19212620 |
| 174 | PAK1 | 0.16569635 |
| 175 | PRKCD | 0.13189231 |
| 176 | CDK4 | 0.12539046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.85960244 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.84402308 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.78930008 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.58569663 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.23365421 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.76062263 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.56310660 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.50822959 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.33322286 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.89447889 |
| 11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.79124534 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.73737755 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.69753616 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.65773655 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62779696 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.62562381 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 2.47084230 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.46021597 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 2.25872715 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.15621664 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 2.07856045 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.05733074 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.04386724 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.00473987 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95984261 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.82511127 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.79619521 |
| 28 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.78983352 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78644883 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78466322 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.77742957 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76776053 |
| 33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.76416573 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.74094577 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71042482 |
| 36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.60843989 |
| 37 | Proteasome_Homo sapiens_hsa03050 | 1.59212723 |
| 38 | Circadian entrainment_Homo sapiens_hsa04713 | 1.54309542 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49566312 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47331870 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45886489 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44563330 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.44440052 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.40716689 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38472358 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36833007 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.36146071 |
| 48 | Taste transduction_Homo sapiens_hsa04742 | 1.35322413 |
| 49 | Insulin secretion_Homo sapiens_hsa04911 | 1.34621051 |
| 50 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.33462821 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 1.32822823 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26862369 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26612649 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.24774252 |
| 55 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.24307466 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.23414549 |
| 57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.22890961 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22546465 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.21268966 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19174698 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 1.18148608 |
| 62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17614518 |
| 63 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.14409725 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14302345 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.14002532 |
| 66 | Ribosome_Homo sapiens_hsa03010 | 1.13231860 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 1.13037241 |
| 68 | Influenza A_Homo sapiens_hsa05164 | 1.05285044 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05046635 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.04332580 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03875236 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.99978951 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98300111 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.98013278 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97514241 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.97371636 |
| 77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.97275669 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.96918355 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.95073609 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93012640 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92880587 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92688360 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87845956 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87738132 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87222538 |
| 86 | Protein export_Homo sapiens_hsa03060 | 0.86689753 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86477140 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86005219 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.84659999 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.82520942 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82011478 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.81777290 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.80280272 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77349744 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75424104 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75208806 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.75177380 |
| 98 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74304469 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73280516 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73217220 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72820320 |
| 102 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69225961 |
| 103 | Bile secretion_Homo sapiens_hsa04976 | 0.67484093 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65709691 |
| 105 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63407463 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63084600 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61317793 |
| 108 | Axon guidance_Homo sapiens_hsa04360 | 0.59692105 |
| 109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59582545 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58485710 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58101773 |
| 112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56931817 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.56697496 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56019497 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.55426970 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.54821359 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54257581 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53912094 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.53743610 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52583350 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51584980 |
| 122 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51492473 |
| 123 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50874201 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50870461 |
| 125 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50753932 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50699994 |
| 127 | RNA degradation_Homo sapiens_hsa03018 | 0.50324568 |
| 128 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49861643 |
| 129 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49695604 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49309672 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48693463 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48586543 |
| 133 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48429623 |
| 134 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48277675 |
| 135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48127556 |
| 136 | Homologous recombination_Homo sapiens_hsa03440 | 0.45997241 |
| 137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45257191 |
| 138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43878002 |
| 139 | Lysosome_Homo sapiens_hsa04142 | 0.42755235 |
| 140 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40474119 |
| 141 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40420339 |
| 142 | Spliceosome_Homo sapiens_hsa03040 | 0.38364286 |
| 143 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36611778 |
| 144 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36401070 |
| 145 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35902408 |
| 146 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35442830 |
| 147 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35307919 |
| 148 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34853532 |
| 149 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34089484 |
| 150 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32967739 |
| 151 | RNA polymerase_Homo sapiens_hsa03020 | 0.32723811 |
| 152 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31949389 |
| 153 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31216337 |
| 154 | Melanoma_Homo sapiens_hsa05218 | 0.31135337 |
| 155 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31115518 |
| 156 | Shigellosis_Homo sapiens_hsa05131 | 0.30660581 |
| 157 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30596030 |
| 158 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30234077 |
| 159 | Peroxisome_Homo sapiens_hsa04146 | 0.30010427 |
| 160 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.29463859 |
| 161 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28748765 |
| 162 | Purine metabolism_Homo sapiens_hsa00230 | 0.26919310 |
| 163 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26917024 |
| 164 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26633864 |
| 165 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26398018 |
| 166 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26303238 |
| 167 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26165830 |
| 168 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26086216 |
| 169 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25983748 |
| 170 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25977880 |
| 171 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.25567292 |
| 172 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25379023 |
| 173 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25177360 |
| 174 | Melanogenesis_Homo sapiens_hsa04916 | 0.24838783 |
| 175 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23834910 |
| 176 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23515568 |
| 177 | Apoptosis_Homo sapiens_hsa04210 | 0.23270782 |
| 178 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.19155506 |
| 179 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.16185375 |
| 180 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16142437 |
| 181 | Hepatitis B_Homo sapiens_hsa05161 | 0.16037770 |
| 182 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14361684 |
| 183 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13621067 |
| 184 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12550529 |
| 185 | Endocytosis_Homo sapiens_hsa04144 | 0.08706440 |
| 186 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.08302080 |

